{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:42:48Z","timestamp":1781710968717,"version":"3.54.5"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Regardless of the source of injury or metabolic dysfunction, fibrosis is a frequent driver of liver pathology. Excessive liver fibrosis is caused by persistent activation of hepatic stellate cells (HSCs), which is defined by myofibroblast activation (MFA) and the epithelial-mesenchymal transition (EMT). Strategies to prevent or reverse this HSC phenotype will be critical for successful treatment of liver fibrosis. We have previously shown that full-term, cell-free human amniotic fluid (cfAF) inhibits MFA and EMT in fibroblasts in vitro. We hypothesize that cfAF treatment can attenuate HSC activation and limit liver fibrosis. We tested if cfAF could prevent liver fibrosis or HSC activation in murine models of liver damage, 3-dimensional hepatic spheroids, and HSC cultures. Administering cfAF prevented weight loss and the extent of fibrosis in mice with chronic liver damage without stimulating deleterious immune responses. Gene expression profiling and immunostaining indicated that cfAF administration in carbon tetrachloride-treated mice reduced EMT- and MFA-related biomarker abundance and modulated transcript levels associated with liver metabolism, immune regulatory pathways, and cell signaling. cfAF treatment lowered MFA biomarker levels in a dose-dependent manner in ex vivo hepatic spheroids. Treating HSCs with cfAF in vitro strongly repressed EMT. Multiomics analyses revealed that it also attenuates TGF\u03b2-induced MFA and inflammation-associated processes. Thus, cfAF treatment prevents liver fibrosis by safeguarding against persistent HSC activation. These findings suggest that cfAF may be a safe and effective therapy for reducing liver fibrosis and preventing the development of cirrhosis and\/or hepatocellular carcinoma.<\/jats:p>","DOI":"10.1093\/stcltm\/szaf026","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T07:46:16Z","timestamp":1748591176000},"source":"Crossref","is-referenced-by-count":1,"title":["Amniotic fluid reduces liver fibrosis by attenuating hepatic stellate cell activation"],"prefix":"10.1093","volume":"14","author":[{"given":"Charles M","family":"Bowen","sequence":"first","affiliation":[{"name":"Division of Transplant, Department of Surgery, University of Texas Medical Branch , Galveston, TX 77555 ,","place":["United States"]},{"name":"John Sealy School of Medicine, University of Texas Medical Branch , Galveston, TX 77555 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Ditmars","sequence":"additional","affiliation":[{"name":"Division of Transplant, Department of Surgery, University of Texas Medical Branch , Galveston, TX 77555 ,","place":["United States"]},{"name":"John Sealy School of Medicine, University of Texas Medical Branch , Galveston, TX 77555 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiyou","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Transplant, Department of Surgery, University of Texas Medical Branch , Galveston, TX 77555 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Marri","family":"Abril","sequence":"additional","affiliation":[{"name":"Division of Transplant, Department of Surgery, University of Texas Medical Branch , Galveston, TX 77555 ,","place":["United States"]},{"name":"John Sealy School of Medicine, University of Texas Medical Branch , Galveston, TX 77555 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ajasin","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, University of Texas Medical Branch , Galveston, TX 77555 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William K","family":"Russell","sequence":"additional","affiliation":[{"name":"Deparment of Biochemistry and Molecular Biology, University of Texas Medical Branch , Galveston, TX 77555 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L","family":"Stevenson","sequence":"additional","affiliation":[{"name":"John Sealy School of Medicine, University of Texas Medical Branch , Galveston, TX 77555 ,","place":["United States"]},{"name":"Department of Pathology, University of Texas Medical Branch , Galveston, TX 77555 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliseo A","family":"Eugenin","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, University of Texas Medical Branch , Galveston, TX 77555 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H","family":"Fair","sequence":"additional","affiliation":[{"name":"Division of Transplant, Department of Surgery, University of Texas Medical Branch , Galveston, TX 77555 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2909-1666","authenticated-orcid":false,"given":"W Samuel","family":"Fagg","sequence":"additional","affiliation":[{"name":"Division of Transplant, Department of Surgery, University of Texas Medical Branch , Galveston, TX 77555 ,","place":["United States"]},{"name":"Deparment of Biochemistry and Molecular Biology, University of Texas Medical Branch , Galveston, TX 77555 ,","place":["United States"]},{"name":"Merakris Therapeutics, RTP Frontier , Research Triangle Park, NC 27709 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"2025070709583912300_CIT0001","article-title":"Liver cirrhosis mortality in the United States: National, State, and Regional Trends, 2000\u20132019","author":"Chen","year":"2022","journal-title":"Surveill Rep"},{"key":"2025070709583912300_CIT0002","doi-asserted-by":"publisher","first-page":"e201997","DOI":"10.1001\/jamanetworkopen.2020.1997","article-title":"Trends in the burden of chronic liver disease among hospitalized US adults","volume":"3","author":"Hirode","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025070709583912300_CIT0003","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/lt.26514","article-title":"Financial burden in adults with chronic liver disease: a scoping review","volume":"28","author":"Ufere","year":"2022","journal-title":"Liver Transpl"},{"key":"2025070709583912300_CIT0004","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J Clin Invest."},{"key":"2025070709583912300_CIT0005","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1440-1746.2011.07002.x","article-title":"What\u2019s new in liver fibrosis? The origin of myofibroblasts in liver fibrosis","volume":"27","author":"Iwaisako","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"2025070709583912300_CIT0006","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"2025070709583912300_CIT0007","doi-asserted-by":"publisher","first-page":"242","DOI":"10.12659\/AOT.914246","article-title":"Risk factors for high mortality on the liver transplant waiting list in times of organ shortage: a single-center analysis","volume":"24","author":"Husen","year":"2019","journal-title":"Ann Transplant"},{"key":"2025070709583912300_CIT0008","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/hep.28812","article-title":"Time trends in the health care burden and mortality of acute on chronic liver failure in the United States","volume":"64","author":"Allen","year":"2016","journal-title":"Hepatol Baltim Md"},{"key":"2025070709583912300_CIT0009","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"2025070709583912300_CIT0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-024-06437-8","article-title":"Activated hepatic stellate cell-derived Bmp-1 induces liver fibrosis via mediating hepatocyte epithelial-mesenchymal transition","volume":"15","author":"Wan","year":"2024","journal-title":"Cell Death Dis"},{"key":"2025070709583912300_CIT0011","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/hep.23196","article-title":"Epithelial-to-mesenchymal transitions in the liver","volume":"50","author":"Choi","year":"2009","journal-title":"Hepatol Baltim Md"},{"key":"2025070709583912300_CIT0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-018-0177-5","article-title":"Activated hepatic stellate cells promote epithelial-to-mesenchymal transition in hepatocellular carcinoma through transglutaminase 2-induced pseudohypoxia","volume":"1","author":"Ma","year":"2018","journal-title":"Commun Biol"},{"key":"2025070709583912300_CIT0013","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/CIRCRESAHA.120.316958","article-title":"Myofibroblasts and fibrosis-mitochondrial and metabolic control of cellular differentiation","volume":"127","author":"Gibb","year":"2020","journal-title":"Circ Res"},{"key":"2025070709583912300_CIT0014","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.3390\/biomedicines10112960","article-title":"Cell-free amniotic fluid and regenerative medicine: current applications and future opportunities","volume":"10","author":"Bowen","year":"2022","journal-title":"Biomedicines"},{"key":"2025070709583912300_CIT0015","article-title":"Fetal Physiology - ClinicalKey","author":"Soens"},{"key":"2025070709583912300_CIT0016","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s12011-015-0557-3","article-title":"Concentrations of mineral in amniotic fluid and their relations to selected maternal and fetal parameters","volume":"172","author":"Suliburska","year":"2016","journal-title":"Biol Trace Elem Res"},{"key":"2025070709583912300_CIT0017","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.placenta.2006.11.009","article-title":"Amniotic fluid water dynamics","volume":"28","author":"Beall","year":"2007","journal-title":"Placenta"},{"key":"2025070709583912300_CIT0018","article-title":"Embryology, amniotic fluid","volume-title":"StatPearls","author":"Fitzsimmons","year":"2022"},{"key":"2025070709583912300_CIT0019","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10561-016-9572-7","article-title":"Collection and characterization of amniotic fluid from scheduled C-section deliveries","volume":"17","author":"Pierce","year":"2016","journal-title":"Cell Tissue Bank"},{"key":"2025070709583912300_CIT0020","doi-asserted-by":"publisher","first-page":"2050313X221100882","DOI":"10.1177\/2050313X221100882","article-title":"Safety and efficacy of acellular human amniotic fluid and membrane in the treatment of non-healing wounds in a patient with chronic venous insufficiency","volume":"10","author":"Ditmars","year":"2022","journal-title":"SAGE Open Med Case Rep"},{"key":"2025070709583912300_CIT0021","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1055\/s-0035-1569481","article-title":"Cryopreserved amniotic suspension for the treatment of knee osteoarthritis","volume":"29","author":"Vines","year":"2016","journal-title":"J Knee Surg"},{"key":"2025070709583912300_CIT0022","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1016\/j.arthro.2021.02.044","article-title":"Safety and efficacy of an amniotic suspension allograft injection over 12 months in a single-blinded, randomized controlled trial for symptomatic osteoarthritis of the knee","volume":"37","author":"Gomoll","year":"2021","journal-title":"Arthroscopy"},{"key":"2025070709583912300_CIT0023","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.arthro.2021.04.034","article-title":"A single injection of amniotic suspension allograft is safe and effective for treatment of mild to moderate hip osteoarthritis: a prospective study","volume":"38","author":"Meadows","year":"2022","journal-title":"Arthroscopy"},{"key":"2025070709583912300_CIT0024","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3390\/ph15040404","article-title":"Allogenic amniotic tissue for treatment of knee and hip osteoarthritis","volume":"15","author":"Gupta","year":"2022","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"2025070709583912300_CIT0025","doi-asserted-by":"publisher","first-page":"583842","DOI":"10.3389\/fmed.2021.583842","article-title":"Case report: administration of amniotic fluid-derived nanoparticles in three severely ill COVID-19 patients","volume":"8","author":"Mitrani","year":"2021","journal-title":"Front Med"},{"key":"2025070709583912300_CIT0026","doi-asserted-by":"publisher","first-page":"101502","DOI":"10.1016\/j.rmcr.2021.101502","article-title":"Treatment of a COVID-19 long hauler with an amniotic fluid-derived extracellular vesicle biologic","volume":"34","author":"Mitrani","year":"2021","journal-title":"Respir Med Case Rep"},{"key":"2025070709583912300_CIT0027","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.3390\/biomedicines10092189","article-title":"Comparative analysis of co-cultured amniotic cell-conditioned media with cell-free amniotic fluid reveals differential effects on epithelial\u2013mesenchymal transition and myofibroblast activation","volume":"10","author":"Liu","year":"2022","journal-title":"Biomedicines"},{"key":"2025070709583912300_CIT0028","doi-asserted-by":"publisher","first-page":"9364","DOI":"10.3390\/ijms21249364","article-title":"Cell-free stem cell-derived extract formulation for regenerative medicine applications","volume":"21","author":"Gupta","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025070709583912300_CIT0029","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0023677215571192","article-title":"The carbon tetrachloride model in mice","volume":"49","author":"Scholten","year":"2015","journal-title":"Lab Anim"},{"key":"2025070709583912300_CIT0030","doi-asserted-by":"publisher","first-page":"15790","DOI":"10.1038\/s41598-020-72801-1","article-title":"Severity assessment in mice subjected to carbon tetrachloride","volume":"10","author":"Ernst","year":"2020","journal-title":"Sci Rep"},{"key":"2025070709583912300_CIT0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-10-79","article-title":"Mouse model of carbon tetrachloride induced liver fibrosis: histopathological changes and expression of CD133 and epidermal growth factor","volume":"10","author":"Fujii","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"2025070709583912300_CIT0032","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1038\/s41598-023-30582-3","article-title":"Mangiferin relieves CCl4-induced liver fibrosis in mice","volume":"13","author":"Zhang","year":"2023","journal-title":"Sci Rep"},{"key":"2025070709583912300_CIT0033","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/0023677215570086","article-title":"Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice","volume":"49","author":"Tolba","year":"2015","journal-title":"Lab Anim"},{"key":"2025070709583912300_CIT0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2021.666138","article-title":"Animal and organoid models of liver fibrosis","volume":"12","author":"Bao","year":"2021","journal-title":"Front Physiol"},{"key":"2025070709583912300_CIT0035","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.3390\/cancers15112871","article-title":"Cellular and molecular mechanisms of liver fibrosis in patients with NAFLD","volume":"15","author":"Sanchez","year":"2023","journal-title":"Cancers"},{"key":"2025070709583912300_CIT0036","doi-asserted-by":"publisher","first-page":"e0119662","DOI":"10.1371\/journal.pone.0119662","article-title":"Differential induction of Ly6G and Ly6C positive myeloid derived suppressor cells in chronic kidney and liver inflammation and fibrosis","volume":"10","author":"H\u00f6chst","year":"2015","journal-title":"PLoS One"},{"key":"2025070709583912300_CIT0037","doi-asserted-by":"publisher","first-page":"100958","DOI":"10.1016\/j.jhepr.2023.100958","article-title":"Heterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosis","volume":"6","author":"Saldarriaga","year":"2023","journal-title":"JHEP Rep"},{"key":"2025070709583912300_CIT0038","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF02723678","article-title":"Cell lines from non-neoplastic liver and hepatocellular carcinoma tissue from a single patient","volume":"32","author":"Noguchi","year":"1996","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"2025070709583912300_CIT0039","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"key":"2025070709583912300_CIT0040","doi-asserted-by":"publisher","first-page":"26657","DOI":"10.1038\/srep26657","article-title":"Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease","volume":"6","author":"Bell","year":"2016","journal-title":"Sci Rep"},{"key":"2025070709583912300_CIT0041","doi-asserted-by":"publisher","first-page":"109393","DOI":"10.1016\/j.celrep.2021.109393","article-title":"Modeling alcohol-associated liver disease in a human Liver-Chip","volume":"36","author":"Nawroth","year":"2021","journal-title":"Cell Rep"},{"key":"2025070709583912300_CIT0042","doi-asserted-by":"publisher","first-page":"7677","DOI":"10.1007\/s11033-021-06774-3","article-title":"RNA sequencing of LX-2 cells treated with TGF-\u03b21 identifies genes associated with hepatic stellate cell activation","volume":"48","author":"Carson","year":"2021","journal-title":"Mol Biol Rep"},{"key":"2025070709583912300_CIT0043","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1349-7006.2005.00103.x","article-title":"The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-beta","volume":"96","author":"Tojo","year":"2005","journal-title":"Cancer Sci"},{"key":"2025070709583912300_CIT0044","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2025070709583912300_CIT0045","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00535-008-2180-y","article-title":"Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies","volume":"43","author":"Li","year":"2008","journal-title":"J Gastroenterol"},{"key":"2025070709583912300_CIT0046","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","article-title":"Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis","volume":"610","author":"Filliol","year":"2022","journal-title":"Nature"},{"key":"2025070709583912300_CIT0047","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene Set Enrichment Analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025070709583912300_CIT0048","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","article-title":"Hepatic fibrosis: concept to treatment","volume":"62","author":"Trautwein","year":"2015","journal-title":"J Hepatol"},{"key":"2025070709583912300_CIT0049","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1053\/j.gastro.2004.03.009","article-title":"Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking","volume":"126","author":"Issa","year":"2004","journal-title":"Gastroenterology"},{"key":"2025070709583912300_CIT0050","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"2025070709583912300_CIT0051","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"2025070709583912300_CIT0052","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","article-title":"Cholangiocyte pathobiology","volume":"16","author":"Banales","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025070709583912300_CIT0053","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3389\/fphar.2017.00748","article-title":"The human amnion epithelial cell secretome decreases hepatic fibrosis in mice with chronic liver fibrosis","volume":"8","author":"Alhomrani","year":"2017","journal-title":"Front Pharmacol"},{"key":"2025070709583912300_CIT0054","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.3390\/cells12162114","article-title":"Amniotic membrane and its derivatives: novel therapeutic modalities in liver disorders","volume":"12","author":"Arki","year":"2023","journal-title":"Cells"},{"key":"2025070709583912300_CIT0055","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1210\/en.2018-00073","article-title":"Amniotic fluid exosome proteomic profile exhibits unique pathways of term and preterm labor","volume":"159","author":"Dixon","year":"2018","journal-title":"Endocrinology"},{"key":"2025070709583912300_CIT0056","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1177\/1933719113518987","article-title":"Amniotic fluid metabolomic analysis in spontaneous preterm birth","volume":"21","author":"Menon","year":"2014","journal-title":"Reprod Sci"},{"key":"2025070709583912300_CIT0057","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","article-title":"The PRIDE database at 20 years: 2025 update","volume":"53","author":"Perez-Riverol","year":"2025","journal-title":"Nucleic Acids Res"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/14\/7\/szaf026\/63688109\/szaf026.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/14\/7\/szaf026\/63688109\/szaf026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T09:58:50Z","timestamp":1751882330000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/doi\/10.1093\/stcltm\/szaf026\/8190179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":57,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,6,25]]}},"URL":"https:\/\/doi.org\/10.1093\/stcltm\/szaf026","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.02.20.639215","asserted-by":"object"}]},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,6,25]]},"article-number":"szaf026"}}